CAG
PAHC icon

Csenge Advisory Group’s Phibro Animal Health PAHC Stock Holding History

Csenge Advisory Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,143
Closed -$452K – 701
2025
Q1 		$452K Buy
26,143
+5,456
+26% +$122K 0.03% 417
2024
Q4 		$434K Buy
+20,687
New +$479K 0.02% 461
2018
Q4 		– Sell
-8
Closed – – 1098
2018
Q3 		$0 Buy
+8
New +$378 ﹤0.01% 1445

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Csenge Advisory Group's PAHC Position: Q2 2025 in Review

Csenge Advisory Group sold out of Phibro Animal Health (PAHC) in Q2 2025, closing a stake of 26,143 shares — an estimated $452K sold.

Csenge Advisory Group first reported a position in PAHC in Q3 2018 and held it in 3 quarters. The position peaked at $452K in Q1 2025. 194 funds tracked by Wall St. Rank hold PAHC as of Q2 2025.

  • Csenge Advisory Group reported no remaining Phibro Animal Health position as of Q2 2025 after selling out during the quarter.
  • Csenge Advisory Group sold 26,143 Phibro Animal Health shares in Q2 2025, an estimated $452K.
  • Csenge Advisory Group first reported a position in Phibro Animal Health in Q3 2018 and held it in 3 quarters.
  • Csenge Advisory Group's Phibro Animal Health position peaked at $452K in Q1 2025.
  • 194 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2025.

Based on Csenge Advisory Group's 13F filing for Q2 2025, filed 6 Aug 2025.